User profiles for Filippo Corponi

Filippo Corponi

University of Edinburgh
Verified email at ed.ac.uk
Cited by 673

Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

F Corponi, C Fabbri, I Bitter, S Montgomery… - European …, 2019 - Elsevier
Second generation antipsychotics (SGAs) are effective options in the treatment of schizophrenia
and mood disorders, each with characteristic efficacy and safety features. In order to …

Genetics of resilience: Implications from genome‐wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and …

S Maul, I Giegling, C Fabbri, F Corponi… - American Journal of …, 2020 - Wiley Online Library
Resilience is the ability to cope with critical situations through the use of personal and socially
mediated resources. Since a lack of resilience increases the risk of developing stress‐…

[HTML][HTML] Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis

S Gomes-da-Costa, W Marx, F Corponi… - Neuroscience & …, 2022 - Elsevier
Lithium remains the gold standard maintenance treatment for Bipolar Disorder (BD). However,
weight gain is a side effect of increasing relevance due to its metabolic implications. We …

The genetics of treatment-resistant depression: a critical review and future perspectives

C Fabbri, F Corponi, D Souery, S Kasper… - International Journal …, 2019 - academic.oup.com
Background One-third of depressed patients develop treatment-resistant depression with
the related sequelae in terms of poor functionality and worse prognosis. Solid evidence …

Pharmacogenetics in psychiatry

F Corponi, C Fabbri, A Serretti - Advances in Pharmacology, 2018 - Elsevier
Mental illness represents a major health issue both at the individual and at the
socioeconomical level. This is partly due to the current suboptimal treatment options: existing …

Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trials

F Corponi, A Serretti, S Montgomery… - International Clinical …, 2017 - journals.lww.com
Cariprazine is a new dopamine D2 and D3 receptor partial agonist antipsychotic. Meta-analytic
evidence of efficacy in acute schizophrenia and specific groups of patients is lacking. We …

[HTML][HTML] Exploring digital biomarkers of illness activity in mood episodes: hypotheses generating and model development study

G Anmella, F Corponi, BM Li, A Mas… - JMIR mHealth and …, 2023 - mhealth.jmir.org
Background: Depressive and manic episodes within bipolar disorder (BD) and major
depressive disorder (MDD) involve altered mood, sleep, and activity, alongside physiological …

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance

C Fabbri, F Corponi, D Albani, I Raimondi… - Progress in Neuro …, 2018 - Elsevier
A candidate gene and a genome-wide approach were combined to study the pharmacogenetics
of antidepressant response and resistance. Investigated genes were selected on the …

[HTML][HTML] Pharmacogenetics and depression: a critical perspective

F Corponi, C Fabbri, A Serretti - Psychiatry investigation, 2019 - ncbi.nlm.nih.gov
Depression leads the higher personal and socio-economical burden within psychiatric disorders.
Despite the fact that over 40 antidepressants (ADs) are available, suboptimal response …

Symptom networks in acute depression across bipolar and major depressive disorders: A network analysis on a large, international, observational study

F Corponi, G Anmella, N Verdolini, I Pacchiarotti… - European …, 2020 - Elsevier
Major Depressive Episode (MDE) is a transdiagnostic nosographic construct straddling
Major Depressive (MDD) and Bipolar Disorder (BD). Prognostic and treatment implications …